• Sanara MedTech mengajukan Form 8-K/A untuk mengoreksi kesalahan pada Item 1.01 dalam laporan 29 Juli 2026.
• Biaya terminasi yang benar: Sanara membayar USD 9,66 juta dalam kondisi tertentu; sebelumnya salah dilaporkan USD 22,54 juta.
• Biaya terminasi yang benar: MiMedx membayar USD 22,54 juta bila Sanara mengakhiri perjanjian akibat kegagalan MiMedx menutup merger; sebelumnya tertukar.
• Perubahan ini hanya membetulkan angka biaya terminasi; bagian lain dari laporan asli tidak diubah.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037112), on August 11, 2026, and is solely responsible for the information contained therein.